Although the population in our study was the same as that in the study by Tan et al. (Tan et al., 2017), there was a difference in the diagnostic yield of FBN1. One possible reason is that the proportion of AD type differed between our study group and that of Tan et al. (Tan et al., 2017). This evidence concerns the gene FBN1 and Alzheimer disease.